IL

Yoel Kashman

This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoel Kashman. Retrieved from https://idiyas.com/inventor/yoel-kashman-65sjhd68

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Yoel Kashman: Innovator in Cancer Treatment

Introduction

Yoel Kashman is a notable inventor based in Illinois, recognized for his contributions to the field of pharmaceutical sciences. His work primarily focuses on the development of novel compounds aimed at treating cancer.

Latest Patents

Kashman's most significant patent is titled "Chemical Derivatives Of Jasmonate, Pharmaceutical Compositions And Methods Of Use Thereof In The Treatment Of Cancer." This invention relates to innovative jasmonate derivatives, methods for their preparation, and pharmaceutical compositions that include these compounds. The methods outlined in this patent emphasize the use of these compounds as chemotherapeutic agents for the prevention and treatment of various cancers.

Career Highlights

Kashman is currently associated with Sepal Pharma Ltd., where he continues to advance his research in cancer treatment. His dedication to developing effective pharmaceutical solutions has positioned him as a key figure in his field.

Collaborations

Throughout his career, Kashman has collaborated with esteemed colleagues, including Eliezer Flescher and M Herzberg. These partnerships have contributed to the advancement of his research and the development of innovative treatments.

Conclusion

Yoel Kashman's work in the pharmaceutical industry, particularly in cancer treatment, showcases his commitment to innovation and improving patient outcomes. His contributions are significant in the ongoing fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…